Sunday, November 02, 2025 4:02:31 PM
Are you suggesting Merck is behind the manipulation until keytruda gets close to being off patent?
I have never come even close to making any assertions of the above which emanates from
heresay of AGGRIEVED NWBO holders without any front line exposure to
where it truly matters vs online panderings
INSTITUTIONS
let alone Hedge Funds
What I have said BEFORE anyone else:
Merck has milked the Oncology market since 2014 with Keytruda
AND Subverted NWBO by withholding the results of 2016 collab w/ NWBO on Colorectal cancer @ MAINZ UNIV.
Unlikely anyone find closure on the above paragraph given the precariousness for EACH.
THERE is a GRAND CANYON DIVIDE
between retailers mindset and that of the INSTITUTIONAL community.
Seen over the last decade as Institutions totally unloaded (I did at the peak)while retailers bought more.
Painful for 99% but should be a Generational Wealth builder just like TNXP which is farther along & without the baggage or history of NWBO (verbatim from what I tweeted a year ago!)
ONLY MAESTRO will unshackle this ALBATROSS with NEWS
RESULTS are all that matter versus unending recriminations amply seen here in last decade:
Too many NEOPHYTES encountered and not many looking themselves in the mirror
NOR admitting like a few have: I should have used an Investment Advisor
DIFFERENT STROKES for DIFFERENT FOLKS
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
